Marianne Cilluffo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UC Riverside-led mouse study stresses MS treatment should be started early
Author:
Iqbal Pittalwala
Share This:
A team led by a biomedical scientist at the University of California, Riverside, reports a drug an estrogen receptor ligand called indazole chloride (IndCl) has the potential to improve vision in patients with multiple sclerosis, or MS.
The study, performed on mice induced with a model of MS and the first to investigate IndCl’s effect on the pathology and function of the complete afferent visual pathway, is published in Brain Pathology. The afferent visual pathway includes the eyes, optic nerve, and all brain structures responsible for receiving, transmitting, and processing visual information. ....

United States , Riverside School , Hawra Karim , Seema Tiwari Woodruff , Steven Nusinowitz , Micah Feri , Hoon Kim , Johna Katzenellenbogen , Joselyns Soto , Batis Golestany , Kelleyc Atkinson , Kelli Lauderdale , Cobi Diaz , Marianne Cilluffo , Mariat Sekyi , University Of California , National Institutes Of Health , National Science Foundation , National Multiple Sclerosis Society , University Of Illinois At Urbana Champaign , Uc Riverside School Of Medicine , Sung Hoon Kim , National Institutes , National Multiple Sclerosis , ஒன்றுபட்டது மாநிலங்களில் , ஆற்றங்கரை பள்ளி ,